Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma

This study has been withdrawn prior to enrollment.

( There was a change of sponsor. The new sponsor company did not wish to conduct the study after all. )

Study NCT00378235 Information provided by Insys Therapeutics Inc

First Received: September 18, 2006 Last Updated: June 30, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given